Science Driven
Therapeutically Focused

Leading the way in
clinical research services
for metabolic diseases

FacebookTwitterLinkedIn

clients, partners and patients
to find new treatments for
NASH, diabetes and obesity

FacebookTwitterLinkedIn
ProSciento Global network of clinical sites and method hubs

Global network of clinical sites and method hubs

FacebookTwitterLinkedIn

PROSCIENTO NEWS

June 15, 2020

ProSciento, Clinical Research Organization (CRO) Focused on Metabolic Diseases, Institutes Rapid COVID-19 Antigen and Antibody Testing at Clinical Research Unit in Southern California Read More »

February 11, 2020

ProSciento Appoints Dr. Michael Grimm as Chief Medical Officer Read More »

ProSciento - Top Work Places

SPOTLIGHT

View Our Presentation

RECENT PUBLICATIONS

May 4, 2020

Clinical Research Considerations for Biosimilar Insulins Read More »

May 1, 2020

Specialized Expertise to Drive Advances in Diabetes Drug and Device Development Read More »

December 14, 2019

Sotagliflozin Decreases Postprandial Glucose and Insulin Concentrations by Delaying Intestinal Glucose Absorption Read More »

Learn about ProSciento services for COVID-19 clinical studies in healthy subjects